New Journal of Chemistry p. 17557 - 17570 (2019)
Update date:2022-08-11
Topics:
Sutradhar, Manas
Martins, Luísa M. D. R. S.
Roy Barman, Tannistha
Kuznetsov, Maxim L.
Guedes Da Silva, M. Fátima C.
Pombeiro, Armando J. L.
The mono-, bi-and tri-nuclear oxidovanadium(v) complexes [VO(OEt)(L1)] (1), [{VO(OEt)(EtOH)}2(L2)] (2) and [{VO(OMe)(H2O)}3(L3)]·2H2O (3) (L1 = 2-hydroxy-(2-hydroxybenzylidene)benzohydrazide, L2 = bis(2-hydroxybenzylidene)terephthalohydrazide and L3 = tris(2-hydroxybenzylidene)benzene-1,3,5-tricarbohydrazide) (3 was synthesized for the first time) were used to investigate the role of vanadium nuclearity in the catalytic oxidation of cyclohexane and cyclohexanol. They are active homogeneous catalysts for the microwave-assisted neat peroxidative oxidation of cyclohexane (with aq. H2O2 to cyclohexanol and cyclohexanone) and cyclohexanol (with aq. tBuOOH to cyclohexanone). A mechanism of the HO radical generation-the rate limiting step of the cyclohexane oxidation by H2O2-was investigated in detail by theoretical DFT methods. The mechanism is different from those usually accepted for the Fenton or Fenton-like systems and it includes (i) coordination of H2O2 to the catalyst molecule, (ii) proton transfer from ligated H2O2 to the methoxy ligand and elimination of the formed methanol molecule and (iii) coordination of the second H2O2 molecule followed by HO-OH bond cleavage to give HO. The activation of the ligated H2O2 towards this cleavage is associated with the redox active nature of the ligand L in the catalyst molecule, which acts (instead of the metal) as the reducing agent of the H2O2 ligand.
View MoreWuxi Innopal International Trade CO.,LTD
Contact:+86-510-80711901-8003
Address:Room 402,Building 5,Longze Garden,No.17,South huanjiu Road,Yixing City, Jiangsu,China
Tangshan Wisdom Trading Co.,Ltd
Contact:86 315 2222979
Address:No.41 BeiXinXi Road, Yangguang building 1-1102 , Tangshan, Hebei, China
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Changzhou Yongfeng Biomedicine Co. Ltd.
website:http://www.yongfengpharm.com
Contact:+86-15006117673
Address:No1,Longxi Road ,Xinbei Zone,Changzhou,JiangsuProvince,PRC
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Doi:10.1016/j.tetlet.2020.152112
(2020)Doi:10.1055/s-1976-25384
(1976)Doi:10.1016/S0040-4020(01)00842-0
(2001)Doi:10.1039/c7gc00432j
(2017)Doi:10.1021/ja01612a020
(1955)Doi:10.1080/07315724.2002.10719243
(1936)